MedPath

Evaluation of the effectiveness of biotin and dexpanthenol ampoules produced by Pars Behruzan Jam company in reducing hair loss

Phase 2
Recruiting
Conditions
hair loss.
Nonscarring hair loss, unspecified
L65.9
Registration Number
IRCT20190210042676N10
Lead Sponsor
Pars Behruzan Jam Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Male or female aged 18-55 years
diffuse and scattered hair loss
General health
Voluntary participation and signing written informed consent

Exclusion Criteria

Pregnancy or breastfeeding
Chronic active scalp disease other than hair loss
Using any prescribed drug or OTC for hair loss within the past 3 months
People with allergies to drug ingredients
Any severe weight loss or strict diet therapy during the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hair lost Changes, based on Global photographic review. Timepoint: Before intervention, 1 and 8 weeks after last injection. Method of measurement: One independent dermatologist will perform clinical assessments in a blinded fashion by scoring every photograph according to the Global photographic review scale .
Secondary Outcome Measures
NameTimeMethod
Hair count changes. Timepoint: Before intervention, 1 and 8 weeks after last injection. Method of measurement: Dermatoscopy By Fotofinder.;Changes in percentage of anagen to telogen. Timepoint: Before intervention, 1 and 8 weeks after last injection. Method of measurement: Dermatoscopy By Fotofinder.
© Copyright 2025. All Rights Reserved by MedPath